Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting

Texas Heart Institute Journal

Volumn 32, Issue 4, 2005, Pages 507-514

  Nussmeier, Nancy A ^a,d   Mora Mangano, Christina ^b   Fontes, Manuel ^c   Schwann, Nanette M ^e   Mangano, Dennis T ^a  

^a Ischemia Research and Education Foundation   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Coronary artery bypass; Estrogen replacement therapy; Female; Hormone replacement therapy; Male; Mortality rate; Postoperative complications; Sex factors; Transfusion, blood; Treatment outcome

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MENOPAUSAL SYNDROME; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; RISK ASSESSMENT; SAFETY; STATISTICAL SIGNIFICANCE;

AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HORMONE REPLACEMENT THERAPY; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33244466737     PISSN: 07302347     EISSN: 07302347     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Koch CG, Khandwala F, Nussmeier N, Blackstone EH. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg 2003;126:2032-43.
2. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation 2002;105:1176-81.
3. O'Rourke DJ, Malenka DJ, Olmstead EM, Quinton HB, Sanders JH Jr, Lahey SJ, et al. Improved in-hospital mortality in women undergoing coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001;71:507-11.
4. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-31.
5. Nussmeier NA, Marino MR, Vaughn WK. Hormone replacement therapy is associated with improved survival in women undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002;124:1225-9.
6. Shackelford DP, Daniels S, Hoffman MK, Chitwood R. Estrogen therapy in women undergoing coronary artery bypass grafting: effect on surgical complications. Obstet Gynecol 2000;95:732-5.
7. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997;79:847-50.
8. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
9. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-9.
10. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [published erratum appears in JAMA 2002;288:1064]. JAMA 2002;288:49-57.
11. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
12. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34.
13. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
14. Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG, Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 2001;104:2300-4.
15. O'Keefe JH Jr, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997;29:1-5.
16. Khan MA, Liu MW, Singh D, Pal A, Chio FL, Lawson D, Dean LS. Long-term (three years) effect of estrogen replacement therapy on major adverse cardiac events in postmenopausal women after intracoronary stenting. Am J Cardiol 2000;86:330-3.
17. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
18. Chaitman BR, Zhou SH, Tamesis B, Rosen A, Terry AB, Zumbehl KM, et al. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol 1996;29:265-77.
19. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-93.
20. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 1997;95:1301-7.
21. White CR, Shelton J, Chen SJ, Darley-Usmar V, Allen L, Nabors C, et al. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 1997;96:1624-30.
22. Oparil S, Chen SJ, Chen YF, Durand JN, Allen L, Thompson JA. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res 1999;44:608-14.
23. Mori T, Durand J, Chen Y, Thompson JA, Bakir S, Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am J Cardiol 2000;85:1276-9.
24. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996;93:577-84.
25. Bakir S, Mori T, Durand J, Chen YF, Thompson JA, Oparil S. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 2000;101:2342-4.
26. Li G, Chen YF, Kelpke SS, Oparil S, Thompson JA. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells. Circulation 2000;101:2949-55.
27. Sudoh N, Toba K, Akishita M, Ako J, Hashimoto M, Iijima K, et al. Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 2001;103:724-9.
28. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, et al. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol 1997;335:185-92.
29. McHugh NA, Merrill GF, Powell SR. Estrogen diminishes postischemic hydroxyl radical production. Am J Physiol 1998;274(6 Pt 2):H1950-4.
30. Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock 2000;14:81-90.
31. Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001;14:162-9.
32. Yokoyama Y, Schwacha MG, Samy TS, Bland KI, Chaudry IH. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002;26:63-76.
33. Campisi R, Nathan L, Pampaloni MH, Schoder H, Sayre JW, Chaudhuri G, Schelbert HR. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002;105:425-30.
34. Rosano GM, Caixeta AM, Chierchia S, Arie S, Lopez-Hidalgo M, Pereira WI, et al. Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease. Circulation 1997;96:2837-41.
35. Lee TM, Su SF, Chou TF, Tsai CH. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty. J Am Coll Cardiol 2002;39:871-7.
36. Polvani G, Marino MR, Roberto M, Dainese L, Parolari A, Pompilio G, et al. Acute effects of 17beta-estradiol on left internal mammary graft after coronary artery bypass grafting. Ann Thorac Surg 2002;74:695-9.
37. Fox AA, Nussmeier NA. Coronary artery bypass graft surgery in women. J Cardiothorac Vasc Anesth 2004;18:344-52.
38. Fox AA, Nussmeier NA. Does gender influence the likelihood or types of complications following cardiac surgery? Semin Cardiothorac Vasc Anesth 2004;8:283-95.
39. Abramov D, Tamariz MG, Sever JY, Christakis GT, Bhatnagar G, Heenan AL, et al. The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg 2000;70:800-6.
40. Utley JR, Wilde EF, Leyland SA, Morgan MS, Johnson HD. Intraoperative blood transfusion is a major risk factor for coronary artery bypass grafting in women. Ann Thorac Surg 1995;60:570-5.
41. Shevde K, Pagala M, Kashikar A, Tyagaraj C, Shahbaz N, Iqbal M, Idupuganti R. Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedure. J Clin Anesth 2000;12:109-16.
42. Boyd GL, Diethelm AG, Gelman S, Langner R, Laskow D, Deierhoi M, Barber WH. Correcting prolonged bleeding during renal transplantation with estrogen or plasma. Arch Surg 1996;131:160-5.
43. Frenette L, Cox J, McArdle P, Eckhoff D, Bynon S. Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation. Anesth Analg 1998;86:1183-6.
44. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-8.
45. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.